Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease

Gaucher disease (GD) is caused by mutations in the <i>GBA</i> gene, leading to deficient activity of the lysosomal enzyme glucocerebrosidase. Among all the symptoms across various organ systems, bone disease is a major concern as it causes high morbidity and reduces quality of life. Enzyme replaceme...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Renuka P. Limgala, Ozlem Goker-Alpan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2020-03-01
Edice:	Biomolecules
Témata:	Gaucher disease bone involvement enzyme replacement therapy substrate reduction therapy Osteoimmunology RANK/RANKL
On-line přístup:	https://www.mdpi.com/2218-273X/10/4/526
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!